Predictive Oncology Engages LifeSci Advisors as Strategic Investor Relations PartnerGlobeNewsWire • 03/14/23
Predictive Oncology highlights successful restructuring and strategic partnerships in letter to shareholdersProactive Investors • 03/09/23
Predictive Oncology and Cvergenx partner up to develop first-ever genomics-based AI approach to personalized radiation therapy and drug discoveryProactive Investors • 02/23/23
Predictive Oncology and Cvergenx announce partnership to develop the first-ever genomics-based approach to precision radiation therapy and drug discovery using artificial intelligenceGlobeNewsWire • 02/23/23
Predictive Oncology launches ACE program to partner with academic and research institutions to advance drug discovery initiativesProactive Investors • 02/21/23
Predictive Oncology appoints business development veteran Pamela Bush as chief business officerProactive Investors • 02/03/23
Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business OfficerGlobeNewsWire • 02/03/23
Predictive Oncology adds Dr Robert F. Murphy to its scientific advisory boardProactive Investors • 01/12/23
Pioneer of Computational Biology Joins the Scientific Advisory Board of Predictive OncologyGlobeNewsWire • 01/12/23
Predictive Oncology adds Chan Zuckerberg Initiative's Marc Malandro to its scientific advisory boardProactive Investors • 12/13/22
Distinguished Innovator in Genomics Joins the Scientific Advisory Board of Predictive OncologyGlobeNewsWire • 12/13/22
Predictive Oncology adds leading biopharma executive Dr Matthew J Hawryluk to its boardProactive Investors • 12/05/22
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D.GlobeNewsWire • 12/05/22
Predictive Oncology reports 45% revenue jump, increased gross profit margin in 3QProactive Investors • 11/11/22
Predictive Oncology strengthens board of directors with life sciences and corporate attorney David SmithProactive Investors • 10/25/22
Predictive Oncology appoints biotech veteran Raymond Vennare as its new CEO and chairmanProactive Investors • 10/20/22
Predictive Oncology Announces New Chief Executive Officer Raymond F. Vennare to Lead Company GrowthGlobeNewsWire • 10/20/22